WO2002050545A3 - Compositions and methods involving staphylococcus aureus protein staau-r9 - Google Patents
Compositions and methods involving staphylococcus aureus protein staau-r9 Download PDFInfo
- Publication number
- WO2002050545A3 WO2002050545A3 PCT/CA2001/001848 CA0101848W WO0250545A3 WO 2002050545 A3 WO2002050545 A3 WO 2002050545A3 CA 0101848 W CA0101848 W CA 0101848W WO 0250545 A3 WO0250545 A3 WO 0250545A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- staphylococcus aureus
- staau
- methods involving
- relates
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01995526A EP1356293A2 (en) | 2000-12-19 | 2001-12-19 | Compositions and methods involving staphylococcus aureus protein staau-r9 |
AU2621202A AU2621202A (en) | 2000-12-19 | 2001-12-19 | Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau r9 |
CA002433386A CA2433386C (en) | 2000-12-19 | 2001-12-19 | Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r9 |
AU2002226212A AU2002226212B2 (en) | 2000-12-19 | 2001-12-19 | Compositions and methods involving staphylococcus aureus protein STAAU-R9 |
JP2002551593A JP2004515251A (en) | 2000-12-19 | 2001-12-19 | Compositions and methods related to the Staphylococcus aureus essential gene and its encoded protein STAAU_R9 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25634900P | 2000-12-19 | 2000-12-19 | |
US60/256,349 | 2000-12-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002050545A2 WO2002050545A2 (en) | 2002-06-27 |
WO2002050545A3 true WO2002050545A3 (en) | 2003-08-21 |
Family
ID=22971918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2001/001848 WO2002050545A2 (en) | 2000-12-19 | 2001-12-19 | Compositions and methods involving staphylococcus aureus protein staau-r9 |
Country Status (6)
Country | Link |
---|---|
US (1) | US7326541B2 (en) |
EP (1) | EP1356293A2 (en) |
JP (1) | JP2004515251A (en) |
AU (2) | AU2002226212B2 (en) |
CA (1) | CA2433386C (en) |
WO (1) | WO2002050545A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6982153B1 (en) * | 1998-12-03 | 2006-01-03 | Targanta Therapeutics, Inc. | DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides |
US7643055B2 (en) * | 2003-04-25 | 2010-01-05 | Aptina Imaging Corporation | Motion detecting camera system |
CN101686964A (en) * | 2007-05-22 | 2010-03-31 | 威斯康星旧生研究基金会 | The anti-bacterial drug targeting of genome maintenance interfaces |
US10849992B1 (en) * | 2015-04-07 | 2020-12-01 | Alector Llc | Methods of screening for sortilin binding antagonists |
CN108795803B (en) * | 2018-06-07 | 2021-08-10 | 上海市水产研究所 | Degrading bacterium capable of efficiently degrading malachite green medicament and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6043038A (en) * | 1998-03-31 | 2000-03-28 | Tularik, Inc. | High-throughput screening assays for modulators of primase activity |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1207253A (en) | 1981-08-17 | 1986-07-08 | Lee D. Simon | T4 dna fragment as a stabilizer for proteins expressed by cloned dna |
CA1327311C (en) | 1987-07-06 | 1994-03-01 | Jesse M. Jaynes | Therapeutic antimicrobial polypeptides, their use and methods for preparation |
DE3735263C1 (en) * | 1987-10-17 | 1988-08-25 | Degussa | Process for the preparation of alkali metal salts of L-2-pyrrolidone-5-carboxylic acid |
JPH09511397A (en) | 1994-04-05 | 1997-11-18 | エクスポネンシャル バイオセラピーズ,インコーポレイテッド | Antibacterial treatment with genotyped bacteriophage |
ATE247711T1 (en) | 1995-06-16 | 2003-09-15 | Nestle Sa | PHAGE RESISTANT STREPTOCOCCUS |
US6037123A (en) * | 1995-09-15 | 2000-03-14 | Microcide Pharmaceuticals, Inc. | Methods of screening for compounds active on Staphylococcus aureus target genes |
US6737248B2 (en) | 1996-01-05 | 2004-05-18 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
US6136557A (en) | 1996-12-13 | 2000-10-24 | Eli Lilly And Company | Strepococcus pneumoniae gene sequence FtsH |
US6380370B1 (en) * | 1997-08-14 | 2002-04-30 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
CA2318574A1 (en) * | 1998-01-27 | 1999-07-29 | The Rockefeller University | Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors |
JP2002531107A (en) | 1998-12-03 | 2002-09-24 | フェージテック,インコーポレーテッド | Development of new antimicrobial agents based on bacteriophage genomics |
AU6749900A (en) | 1999-07-29 | 2001-02-19 | Rockefeller University, The | Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors |
GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
-
2001
- 2001-12-19 AU AU2002226212A patent/AU2002226212B2/en not_active Ceased
- 2001-12-19 EP EP01995526A patent/EP1356293A2/en not_active Withdrawn
- 2001-12-19 JP JP2002551593A patent/JP2004515251A/en active Pending
- 2001-12-19 WO PCT/CA2001/001848 patent/WO2002050545A2/en active Application Filing
- 2001-12-19 CA CA002433386A patent/CA2433386C/en not_active Expired - Fee Related
- 2001-12-19 US US10/025,222 patent/US7326541B2/en not_active Expired - Fee Related
- 2001-12-19 AU AU2621202A patent/AU2621202A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6043038A (en) * | 1998-03-31 | 2000-03-28 | Tularik, Inc. | High-throughput screening assays for modulators of primase activity |
Non-Patent Citations (1)
Title |
---|
DATABASE NCBI [online] XP002236249, retrieved from NCBI Database accession no. ab001896 * |
Also Published As
Publication number | Publication date |
---|---|
US7326541B2 (en) | 2008-02-05 |
EP1356293A2 (en) | 2003-10-29 |
CA2433386C (en) | 2006-11-21 |
AU2002226212B2 (en) | 2006-11-16 |
JP2004515251A (en) | 2004-05-27 |
CA2433386A1 (en) | 2002-06-27 |
AU2621202A (en) | 2002-07-01 |
WO2002050545A2 (en) | 2002-06-27 |
US20030003444A1 (en) | 2003-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002077183A9 (en) | Identification of essential genes in microorganisms | |
WO2005042716A3 (en) | Nucleic acid binding oligonucleotides | |
NZ316787A (en) | Methods and compositions for the selective modification of nucleic acids | |
WO2000044928A3 (en) | Materials and methods for the purification of polyelectrolytes | |
WO2003016482A3 (en) | Methyltransferase genes and uses thereof | |
WO2002095055A8 (en) | Compositions and methods for use in isolation of nucleic acid molecules | |
WO2001068824A3 (en) | Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items | |
WO2003056904A3 (en) | Transgenic plants expressing civps or intein modified proteins and related method | |
WO2003034812A3 (en) | Aromatic methyltransferases and uses thereof | |
WO2004013312A3 (en) | Tocopherol biosynthesis related genes and uses thereof | |
WO2001048209A3 (en) | Genes identified as required for proliferation of e. coli | |
WO2002012478A8 (en) | Methyl-d-erythritol phosphate pathway genes | |
EP1130091A3 (en) | Bacterial RNaseP Proteins and their use in identifying antibacterial compounds | |
WO2000044906A3 (en) | GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) | |
WO2005058945A3 (en) | Gene variants coding for proteins from the metabolic pathway of fine chemicals | |
WO2001077292A3 (en) | Novel signal transduction molecules | |
WO2002050545A3 (en) | Compositions and methods involving staphylococcus aureus protein staau-r9 | |
WO2006035311A3 (en) | Group a streptococcus crge protein | |
WO2003008572A8 (en) | Methods of creating genetic diversity | |
WO2001066752A3 (en) | Reproduction-specific genes | |
WO2002050106A3 (en) | Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 | |
WO2001034810A3 (en) | Genes essential for microbial proliferation | |
DE69838615D1 (en) | ppGpp-Synthetase and expression systems for the improved production of proteins | |
WO2004110367A3 (en) | Sdr proteins from staphylococcus capitis and their use in preventing and treating infections | |
WO2003068975A1 (en) | ss-LACTAMASE/ANMINOGLYCOSIDES MODIFYING ENZYME GENES, THEIR FUSION GENE AND THE EXPRESSION PRODUCTS, THE COMPOSITION THEREOF, AND THEIR USES IN MEDICINE AND ENVIRONMENTAL PROTECTION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2433386 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002551593 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002226212 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001995526 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001995526 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |